Biotechnology and the Challenge of Property

Property Rights in Dead Bodies, Body Parts, and Genetic Information

Häftad, Engelska, 2016

Av Remigius N. Nwabueze

859 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Finns i fler format (1)

Inbunden

2 419 kr

Skickas inom 10-15 vardagar

Biotechnology and the Challenge of Property addresses the question of how the advancement of property law is capable of controlling the interests generated by the engineering of human tissues. Through a comparative consideration of non-Western societies and industrialized cultures, this book addresses the impact of modern biotechnology, and its legal accommodation on the customary conduct and traditional beliefs which shape the lives of different communities. Nwabueze provides an introduction to the legal regulation of the evolving uses of human tissues, and its implications for traditional knowledge, beliefs and cultures.

Produktinformation

Utgivningsdatum2016-11-28
Mått156 x 234 x undefined mm
Vikt453 g
FormatHäftad
SpråkEngelska
Antal sidor392
FörlagTaylor & Francis Ltd
ISBN9781138271449

Tillhör följande kategorier

Hälso- och sjukvårdsrätt inom Juridik

Preface, Acknowledgements, Table of Cases, Table of Statutes, Introduction, 1. The Nature, Uses and Meaning of Property, 2. Biotechnology and the Property Jurisprudence on the Human Body and Parts, 3. Cultural and Ontological Contexts of Biotechnology and the Human Body, 4. DNA Banks and Proprietary Interests in Biosamples and Genetic Information, 5. Remedies for Interference with Dead Bodies and Body Parts: Property and Non-Property Approaches, 6. Property and Traditional Knowledge, Bibliography, Index

'This book draws attention to the consequences of using the concept of property to deal with ethical and policy issues raised by new biotechnology. It combines an analysis of the common law with a discussion of new legal initiatives designed to assist developing countries in dealing with these issues. This book adds a distinct voice to the debate about the legal tools we should use to control new biotechnologies in a developing world context and should appeal to all those who are interested in these issues.' Trudo Lemmens, University of Toronto